PRB2

Chr 12

proline rich protein BstNI subfamily 2

Also known as: IB-9, PRPPRB1, Ps, cP7

This gene encodes a proline-rich salivary glycoprotein that is secreted from the parotid glands and functions in oral health maintenance. Mutations in PRB2 are associated with pediatric neurological conditions as described in GeneReviews, though the gene shows very low constraint to loss-of-function variants. The inheritance pattern and specific clinical features require consultation of the GeneReviews entry for this gene.

Summary from RefSeq
Research Assistant →
0
Active trials
4
Pubs (1 yr)
42
P/LP submissions
0%
P/LP missense
1.97
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPRB2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 134 VUS of 192 total submissions
📖
GeneReview available — PRB2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.97LOEUF
pLI 0.000
Z-score -2.54
OE 2.42 (1.121.97)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-3.90Z-score
OE missense 1.75 (1.601.90)
378 obs / 216.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE2.42 (1.121.97)
00.351.4
Missense OE1.75 (1.601.90)
00.61.4
Synonymous OE1.59
01.21.6
LoF obs/exp: 9 / 3.7Missense obs/exp: 378 / 216.6Syn Z: -3.97
DN
0.93top 5%
GOF
0.91top 5%
LOF
0.3452th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

192 submitted variants in ClinVar

Classification Summary

Pathogenic39
Likely Pathogenic3
VUS134
Likely Benign13
Benign1
39
Pathogenic
3
Likely Pathogenic
134
VUS
13
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
39
0
39
Likely Pathogenic
0
0
3
0
3
VUS
0
130
4
0
134
Likely Benign
0
4
0
9
13
Benign
0
0
1
0
1
Total0134479190

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PRB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →